Lisa LaGuardia
Overview
Explore the profile of Lisa LaGuardia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
346
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naseem Z, Mejia-Perez L, Friedman K, LaGuardia L, Walsh R, Burke C
ACG Case Rep J
. 2025 Feb;
12(2):e01616.
PMID: 39911375
Individuals with a germline pathogenic variant in the gene have a lifetime risk of advanced diffuse gastric cancer (DGC) of up to 10.3% and a 37%-52% risk of breast cancer,...
2.
Mejia Perez L, OMalley M, Chatterjee A, Lyu R, Yang Q, Cruise M, et al.
Fam Cancer
. 2024 Sep;
23(4):617-626.
PMID: 39261344
To determine the preoperative detection of signet ring cancer cells (SRC) on upper endoscopy (EGD) in patients with CDH1 pathogenic variant (PV) undergoing gastrectomy. To evaluate the development of advanced...
3.
Hajj Ali A, Burke C, OMalley M, LaGuardia L, Liska D, Macaron C
J Clin Gastroenterol
. 2023 Aug;
58(6):596-601.
PMID: 37646505
Background: Colonic polyposis of unknown etiology (CPUE) is defined as ≥10 cumulative colonic adenomas without a detectable germline pathogenic variant. Surveillance for patients with >100 adenomas is recommended, similar to...
4.
El Halabi J, LaGuardia L, Walsh R, Kwon C, Menon K, Liska D, et al.
Fam Cancer
. 2022 Jul;
22(1):77-82.
PMID: 35896845
Familial adenomatous polyposis (FAP) is characterized by colorectal polyposis and extracolonic tumors. Adenocarcinoma of the pancreas and hepatocellular carcinoma are rare in FAP. In this case series, we describe a...
5.
Faisal M, Burke C, Liska D, Lightner A, Leach B, OMalley M, et al.
World J Clin Oncol
. 2022 Feb;
13(1):49-61.
PMID: 35116232
Background: Individuals with Lynch syndrome (LS) and hereditary non-polyposis colorectal cancer (HNPCC) are at increased risk of both colorectal cancer and other cancers. The interplay between immunosuppression, a comorbid inflammatory...
6.
Khare A, Burke C, Heald B, OMalley M, LaGuardia L, Milicia S, et al.
J Clin Gastroenterol
. 2021 Jul;
56(3):e183-e188.
PMID: 34231499
Goals And Background: Phosphatase and tensin homolog hamartoma tumor syndrome (PHTS) is an inherited disorder that increases the risk for cancer in multiple organ systems, including breast, endometrial, thyroid, and...
7.
Faisal M, Burke C, Achkar J, Click B, OMalley M, LaGuardia L, et al.
Fam Cancer
. 2021 Apr;
21(2):189-195.
PMID: 33822277
Clinicians may be hesitant to prescribe biologics or immunomodulators to individuals with familial adenomatous polyposis (FAP) and comorbid inflammatory disease (CID) because of increased cancer risk. Our aim was to...
8.
Mehta N, Shah R, Yoon J, OMalley M, LaGuardia L, Mankaney G, et al.
Clin Gastroenterol Hepatol
. 2020 Jun;
19(4):760-767.
PMID: 32492482
Background & Aims: Ampullary and duodenal cancer are the leading causes of death in patients with familial adenomatous polyposis (FAP) after colectomy has been performed. Risk of duodenal cancer is...
9.
Mankaney G, Cruise M, Sarvepalli S, Bhatt A, Arora Z, Baggot B, et al.
Gastrointest Endosc
. 2020 May;
92(3):755-762.
PMID: 32380015
Background And Aims: Gastric cancer is an extracolonic manifestation of familial adenomatous polyposis (FAP) and is associated with high-risk gastric polyps. There are no known endoscopic criteria to identify these...
10.
Nieminen T, Walker C, Olkinuora A, Genutis L, OMalley M, Wakely P, et al.
Thyroid
. 2020 Feb;
30(3):380-388.
PMID: 32024448
Familial adenomatous polyposis (FAP) is a condition typically caused by pathogenic germline mutations in the gene. In addition to colon polyps, individuals with FAP have a substantially increased risk of...